Correlation Between Metacon AB and Spago Nanomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Metacon AB and Spago Nanomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacon AB and Spago Nanomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacon AB and Spago Nanomedical AB, you can compare the effects of market volatilities on Metacon AB and Spago Nanomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacon AB with a short position of Spago Nanomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacon AB and Spago Nanomedical.

Diversification Opportunities for Metacon AB and Spago Nanomedical

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Metacon and Spago is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Metacon AB and Spago Nanomedical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spago Nanomedical and Metacon AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacon AB are associated (or correlated) with Spago Nanomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spago Nanomedical has no effect on the direction of Metacon AB i.e., Metacon AB and Spago Nanomedical go up and down completely randomly.

Pair Corralation between Metacon AB and Spago Nanomedical

Assuming the 90 days trading horizon Metacon AB is expected to under-perform the Spago Nanomedical. In addition to that, Metacon AB is 1.21 times more volatile than Spago Nanomedical AB. It trades about -0.32 of its total potential returns per unit of risk. Spago Nanomedical AB is currently generating about 0.26 per unit of volatility. If you would invest  22.00  in Spago Nanomedical AB on November 7, 2024 and sell it today you would earn a total of  5.00  from holding Spago Nanomedical AB or generate 22.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Metacon AB  vs.  Spago Nanomedical AB

 Performance 
       Timeline  
Metacon AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Metacon AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Spago Nanomedical 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Spago Nanomedical AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Spago Nanomedical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Metacon AB and Spago Nanomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Metacon AB and Spago Nanomedical

The main advantage of trading using opposite Metacon AB and Spago Nanomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacon AB position performs unexpectedly, Spago Nanomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spago Nanomedical will offset losses from the drop in Spago Nanomedical's long position.
The idea behind Metacon AB and Spago Nanomedical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance